Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph J Muldoon

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nature Protocols|March 3, 2025
Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cellsSrishti U Sahu, Madalena Castro, Joseph J Muldoon, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 2, 2020
Nanofountain Probe Electroporation Enables Versatile Single-Cell Intracellular Delivery and Investigation of Postpulse Electropore DynamicsSamba Shiva Prasad Nathamgari, Nibir Pathak, Vincent Lemaitre, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Ultra-high efficiency T cell reprogramming at multiple loci with SEED-SelectionChristopher R Chang, Vivasvan S Vykunta, Daniel B Goodman, et al.
ACS Synthetic Biology|May 2, 2025
Engineered Feedback Employing Natural Hypoxia-Responsive Factors Enhances Synthetic Hypoxia BiosensorsKathleen S Dreyer, Patrick S Donahue, Jonathan D Boucher, et al.
Cell|January 13, 2023
An evolved AAV variant enables efficient genetic engineering of murine T cellsWilliam A Nyberg, Jonathan Ark, Angela To, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Bispecific T cell engagers control solid tumors through clonal replacement and IL2-driven effector differentiation of CD8 T cellsMatthias Obenaus, Clara L Poupault, Christopher S McGinnis, et al.
Nature Biomedical Engineering|May 5, 2023
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytesDana V Foss, Joseph J Muldoon, David N Nguyen, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Developing, characterizing and modeling CRISPR-based point-of-use pathogen diagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
Nature Biotechnology|February 5, 2025
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple lociChristopher R Chang, Vivasvan S Vykunta, Jae Hyun J Lee, et al.
ACS Synthetic Biology|December 13, 2024
Developing, Characterizing, and Modeling CRISPR-Based Point-of-Use Pathogen DiagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature Protocols|March 3, 2025
Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cellsSrishti U Sahu, Madalena Castro, Joseph J Muldoon, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 2, 2020
Nanofountain Probe Electroporation Enables Versatile Single-Cell Intracellular Delivery and Investigation of Postpulse Electropore DynamicsSamba Shiva Prasad Nathamgari, Nibir Pathak, Vincent Lemaitre, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Ultra-high efficiency T cell reprogramming at multiple loci with SEED-SelectionChristopher R Chang, Vivasvan S Vykunta, Daniel B Goodman, et al.
ACS Synthetic Biology|May 2, 2025
Engineered Feedback Employing Natural Hypoxia-Responsive Factors Enhances Synthetic Hypoxia BiosensorsKathleen S Dreyer, Patrick S Donahue, Jonathan D Boucher, et al.
Cell|January 13, 2023
An evolved AAV variant enables efficient genetic engineering of murine T cellsWilliam A Nyberg, Jonathan Ark, Angela To, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Bispecific T cell engagers control solid tumors through clonal replacement and IL2-driven effector differentiation of CD8 T cellsMatthias Obenaus, Clara L Poupault, Christopher S McGinnis, et al.
Nature Biomedical Engineering|May 5, 2023
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytesDana V Foss, Joseph J Muldoon, David N Nguyen, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Developing, characterizing and modeling CRISPR-based point-of-use pathogen diagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
Nature Biotechnology|February 5, 2025
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple lociChristopher R Chang, Vivasvan S Vykunta, Jae Hyun J Lee, et al.
ACS Synthetic Biology|December 13, 2024
Developing, Characterizing, and Modeling CRISPR-Based Point-of-Use Pathogen DiagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
Pageof 3